Optimization of prednisolone acetate-loaded chitosan microspheres using a 23 factorial design for preventing restenosis

被引:12
作者
Sarisozen, Can [1 ]
Arica, Betuel [1 ]
Orman, Mehmet N. [2 ]
Hincal, A. Atilla [1 ]
Calis, Sema [1 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Ege Univ, Fac Med, Dept Biostat & Med Informat, TR-35100 Bornova, Turkey
关键词
Microspheres; prednisolone acetate; chitosan; factorial design; spray-drying; DRUG-ELUTING STENTS; CONTROLLED-RELEASE; DELIVERY; ENCAPSULATION;
D O I
10.3109/10717541003667780
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prednisolone acetate (PA)-loaded microspheres were prepared by the spray-drying technique using different polymer (1% and 2%) and drug concentrations (10% and 20%). To obtain the optimum formulation, a three-factor two-level (2<SU3</SU) design was employed. The independent variables were polymer molecular weight, polymer concentration, and theoretical drug loading. Responses were the particle size, percentage of encapsulation efficiency, and the t(50%) release. The best formulation was prepared with 20% of PA and 1% of chitosan with medium molecular weight showing relative good yield of production (48.0 +/- 6.7%) and encapsulation efficiency (45.7 +/- 0.3%), and released the drug at a constant rate in 11 days.</.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 29 条
[1]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[2]  
ARICA B, 2002, CHITOSAN PHARM CHEM, P71
[3]  
ARICA B, 1994, 9 INT S MICR PAR FRA, P136
[4]   Drug-eluting stents: A multidisciplinary success story [J].
Burt, HM ;
Hunter, WL .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (03) :350-357
[5]  
Chorny M, 2000, CRIT REV THER DRUG, V17, P249
[6]   Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan microspheres by spray drying [J].
Desai, KGH ;
Park, HJ .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (02) :179-192
[7]   Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-β-cyclodextrin inclusion complex [J].
Filipovic-Grcic, J ;
Voinovich, D ;
Moneghini, M ;
Becirevic-Lacan, M ;
Magarotto, L ;
Jalsenjak, I .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 9 (04) :373-379
[8]   Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation [J].
Filipovic-Grcic, J ;
Perissutti, B ;
Moneghini, M ;
Voinovich, D ;
Martinac, A ;
Jalsenjak, I .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (07) :921-931
[9]   Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide [J].
Ganza-González, A ;
Anguiano-Igea, S ;
Otero-Espinar, FJ ;
Méndez, JB .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 48 (02) :149-155
[10]   Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies [J].
Gavini, E ;
Hegge, AB ;
Rassu, G ;
Sanna, V ;
Testa, C ;
Pirisino, G ;
Karlsen, J ;
Giunchedi, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (01) :9-15